Disorder Of Fatty Acid And Ketone Body Metabolism C5681281
Inherited metabolic disorders disrupting the body's ability to convert fats and ketones into energy. These conditions typically manifest in infancy. Dietary modifications and supportive care are primary approaches.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Hypoglycemia
Metabolic acidosis
Cardiomyopathy
Rhabdomyolysis
Fatigue or weight changes
(metabolic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Specialized Metabolic Diet
Lifelong dietary management avoiding fasting periods through frequent small meals with complex carbohydrates as primary energy source, limiting fatty food intake to reduce toxic metabolite accumulation.
Fasting Avoidance Protocol
Strict adherence to feeding schedules every 2-4 hours during waking hours and overnight feeds via gastrostomy if needed to prevent dangerous metabolic crises during catabolic states.
Additional treatment options
L-Carnitine Supplementation
Carnitine replacement therapy to support fatty acid transport into mitochondria and help remove toxic acylcarnitine metabolites that accumulate in fatty acid oxidation disorders.
medicationEmergency IV Glucose Administration
Hospital-based intervention providing intravenous dextrose during acute metabolic decompensation to suppress fatty acid oxidation and prevent rhabdomyolysis and cardiac complications.
procedureMetabolic Laboratory Surveillance
Regular monitoring of acylcarnitine profiles, liver function tests, creatine kinase, and cardiac biomarkers to detect metabolic decompensation early and adjust management.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Disorder Of Fatty Acid And Ketone Body Metabolism C5681281?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Disorder Of Fatty Acid And Ketone Body Metabolism C5681281. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy